Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 21, 2016
Phase I study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-Hodgkin's lymphomaLin Gui, Xiaohong Han, Xiaohui He, et al.
Plant Science : an International Journal of Experimental Plant Biology|March 27, 2018
CsMYB5a and CsMYB5e from Camellia sinensis differentially regulate anthocyanin and proanthocyanidin biosynthesisXiaolan Jiang, Keyi Huang, Guangshun Zheng, et al.
Chinese Journal of Cancer|September 16, 2015
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphomaYuankai Shi, Ping Zhou, Xiaohong Han, et al.
Chronic Diseases and Translational Medicine|September 10, 2021
Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized studyHongnan Mo, Peng Liu, Yan Qin, et al.
Asia-Pacific Journal of Clinical Oncology|January 20, 2017
Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicityYouwu Shi, Peng Liu, Shengyu Zhou, et al.
The Plant Journal : for Cell and Molecular Biology|April 19, 2022
Insights into acylation mechanisms: co-expression of serine carboxypeptidase-like acyltransferases and their non-catalytic companion paralogsShengbo Yao, Yajun Liu, Juhua Zhuang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2020
Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I studyJianliang Yang, Lihou Dong, Sheng Yang, et al.
Molecular & Cellular Proteomics : MCP|January 31, 2013
Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapiesXijun Wang, Aihua Zhang, Ping Wang, et al.
Pageof 10